InnoONE™ is an integral part of Servier’s CMO service, offering comprehensive support throughout the process of bringing your high potency product to market. Drawing on over 30 years of expertise at our Arklow site in Ireland, including over a decade of experience in high containment operations, we have recently introduced a state-of-the-art EPO5 suite. This cutting-edge technology enables manufacturing to achieve levels of <1μg/m3, reinforcing our commitment to excellence and innovation.
Join us for an exclusive interview with Pascal Baraffe, the Managing Director who oversees operations at our Arklow site in Ireland. Pascal gives us an insight into the revolutionary InnoONE™ suite, shedding light on its technology and capabilities.
Watch the video below to discover the transformative potential of InnoONE™ and how it can revolutionise your pharmaceutical manufacturing processes. 🚀
Transcript of the interview with Pascal Baraffe :
Question 1: What is InnoONE™?
“InnoONE™ is our high containment facility located on our Arklow, Ireland site for the manufacture of High potent solid oral dosage products. The unit has been designed with containment engineered into the suite itself, mitigating the risk of exposure for the operators during the manufacturing process.”
Question 2: Why have a high containment tool on a pharmaceutical site?
“With the increasing number of high-potent products, there was a requirement for a facility to safely produce this type of finished dosage form in a contained environment for both manufacturing and operator’s safety against exposure.”
Question 3: What are the advantages of the InnoONE™ suite at Arklow?
“The InnoONE™ Suite in Arklow is a high contained system that allows in-place cleaning of equipment and eliminates the exposure of the operators and area to highly potent products. With flexible batch size, blister packaging capabilities, serialization and aggregation expertise the new Suite enables Servier to provide a fully integrated end-to-end service.”
Question 4: What kind of products can we make at InnoONE™?
“We can manufacture Solid Oral Dosage Tablets and package capsules, with variable batch sizes from 20 – 40 kgs.”
Question 5: Re-explaining the OEB5
“Every compound has a potency risk level. The potency risk is based on the compounds Occupational Exposure Limit (OEL).
Categories of potency have been developed by a number of recognised bodies. Today, there is no globally harmonised approach to categorising potent compounds.
Servier have adopted a widely recognised 5 band system, (Occupational Exposure Band), OEB 1, 2, 3, 4 and 5. The most potent compounds are OEB5 where the safe OEL is less than 1 µg/m3.”
🌐 InnoONE™ embodies Servier’s quest for excellence and innovation in pharmaceutical manufacturing. With these explanations from Pascal Baraffe, it’s easier to understand the transformative power inherent in InnoONE™. Its cutting-edge technology not only ensures exceptional product quality, but also prioritises operator safety and well-being, setting a new standard for industry best practice.
Packed with cutting-edge features and an unwavering commitment to exceeding industry benchmarks, InnoONE™ is ready to revolutionise your pharmaceutical production processes. Whether you’re looking to improve efficiency, ensure regulatory compliance or streamline operations, InnoONE™ offers bespoke solutions to meet your unique needs.
Please contact us today to find out how InnoONE™ can be customised to perfectly align with your goals and support your success in the dynamic pharmaceutical market. Let us partner with you to unlock the full potential of InnoONE™ and propel your business to new heights.
To find out more, also visit the InnoONE™ dedicated page ⬇
